Page last updated: 2024-11-05

tilorone and Alveolitis, Fibrosing

tilorone has been researched along with Alveolitis, Fibrosing in 1 studies

Tilorone: An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.
tilorone : A member of the class of fluoren-9-ones that is 9H-fluoren-9-one which is substituted by a 2-(diethylamino)ethoxy group at positions 2 and 7. It is an interferon inducer and a selective alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist. Its hydrochloride salt is used as an antiviral drug.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vartiainen, V1
Raula, J1
Bimbo, LM1
Viinamäki, J1
Backman, JT1
Ugur, N1
Kauppinen, E1
Sutinen, E1
Joensuu, E1
Koli, K1
Myllärniemi, M1

Other Studies

1 other study available for tilorone and Alveolitis, Fibrosing

ArticleYear
Pulmonary administration of a dry powder formulation of the antifibrotic drug tilorone reduces silica-induced lung fibrosis in mice.
    International journal of pharmaceutics, 2018, Jun-10, Volume: 544, Issue:1

    Topics: Administration, Inhalation; Animals; Cell Line; Dry Powder Inhalers; Humans; Leucine; Lung; Male; Mi

2018